Newsletter | August 8, 2026

08.08.26 -- Life Science Leader Newsletter - Best Of July

JULY'S BEST FEATURED EDITORIAL

Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D.

On Business of Biotech, Al Sandrock, M.D., Ph.D., CEO of Voyager Therapeutics, explores tau as a key Alzheimer’s target and how gene therapy delivery could transform treatment at scale.
 

JULY'S BEST INDUSTRY INSIGHTS

Achieving Successful Technology Transfer Through Risk Management

Early risk identification is critical to predictable technology transfer. Learn how data-driven modeling, multivariate analysis, and proactive collaboration help keep manufacturing timelines on track.

Advantages Of Integrated Clinical Trial Management

Disconnected trial systems slow sites and patients. Centralizing logistics, payments, and data improves visibility, reduces admin work, and keeps enrollment on track for more patient‑focused studies.

Collaborative Supply Chain Management In A Fragmented World

Biopharma supply chains are under pressure. As regionalization accelerates, success depends on agility, trust, and new approaches to collaboration that can withstand ongoing global uncertainty.

Connect With Life Science Leader: